Ironwood shares rise after favorable report

A top executive at Ironwood Pharmaceuticals described the company's direct-to-consumer ad campaign to promote its drug for irritable bowel syndrome with constipation "one of the strongest in the industry over the last couple of years," driving $297 million in sales last year. The Cambridge company gave its 2014 annual report late Friday, with revenue for the last four months coming in slightly above analyst estimates, but a larger net loss than most anticipated. Today, investors boosted the share…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news